Sunzen Biotech Bhd (0148) - Total Assets
Based on the latest financial reports, Sunzen Biotech Bhd (0148) holds total assets worth RM159.04 Million MYR (≈ $39.93 Million USD) as of March 2024. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Sunzen Biotech Bhd - Total Assets Trend (2016–2023)
This chart illustrates how Sunzen Biotech Bhd's total assets have evolved over time, based on quarterly financial data. Also see 0148 market cap overview for the company's overall valuation and market capitalisation.
Sunzen Biotech Bhd - Asset Composition Analysis
Current Asset Composition (December 2023)
Sunzen Biotech Bhd's total assets of RM159.04 Million consist of 33.6% current assets and 66.4% non-current assets. Review 0148 liabilities breakdown to assess the company's total debt and financial obligations.
| Asset Category | Amount (MYR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | RM0.00 | 12.6% |
| Accounts Receivable | RM14.79 Million | 8.7% |
| Inventory | RM9.47 Million | 5.6% |
| Property, Plant & Equipment | RM0.00 | 0.0% |
| Intangible Assets | RM0.00 | 0.0% |
| Goodwill | RM0.00 | 0.0% |
Asset Composition Trend (2016–2023)
This chart illustrates how Sunzen Biotech Bhd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See 0148 stock price for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Sunzen Biotech Bhd's current assets represent 33.6% of total assets in 2023, a decrease from 66.8% in 2016.
- Cash Position: Cash and equivalents constituted 12.6% of total assets in 2023, down from 47.6% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2016.
- Asset Diversification: The largest asset category is accounts receivable at 8.7% of total assets.
Sunzen Biotech Bhd Competitors by Total Assets
Key competitors of Sunzen Biotech Bhd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Nestle S.A.
SW:NESN
|
Switzerland | CHF128.38 Billion |
|
Saputo Inc
TO:SAP
|
Canada | CA$13.61 Billion |
|
ORKLA ADR/1 NK 625
F:OKL0
|
Germany | €88.70 Billion |
|
The a2 Milk Company Ltd
AU:A2M
|
Australia | AU$1.96 Billion |
|
Guangdong Haid Group Co Ltd
SHE:002311
|
China | CN¥55.29 Billion |
|
Cisarua Mountain Dairy Tbk PT
JK:CMRY
|
Indonesia | Rp9.48 Trillion |
|
Qianhe Condiment&Food Co Ltd
SHG:603027
|
China | CN¥4.46 Billion |
|
Chacha Food Co Ltd
SHE:002557
|
China | CN¥9.69 Billion |
Sunzen Biotech Bhd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 6.71 | 6.00 | 3.82 |
| Quick Ratio | 5.57 | 4.57 | 3.16 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | RM45.83 Million | RM33.62 Million | RM57.85 Million |
Sunzen Biotech Bhd - Advanced Valuation Insights
This section examines the relationship between Sunzen Biotech Bhd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.48 |
| Latest Market Cap to Assets Ratio | 0.25 |
| Asset Growth Rate (YoY) | 12.8% |
| Total Assets | RM170.35 Million |
| Market Capitalization | $43.17 Million USD |
Valuation Analysis
Below Book Valuation: The market values Sunzen Biotech Bhd's assets below their book value (0.25x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Sunzen Biotech Bhd's assets grew by 12.8% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Sunzen Biotech Bhd (2016–2023)
The table below shows the annual total assets of Sunzen Biotech Bhd from 2016 to 2023.
| Year | Total Assets | Change |
|---|---|---|
| 2023-12-31 | RM170.35 Million ≈ $42.77 Million |
+12.85% |
| 2022-12-31 | RM150.96 Million ≈ $37.90 Million |
+1.51% |
| 2021-12-31 | RM148.71 Million ≈ $37.34 Million |
+20.70% |
| 2020-12-31 | RM123.20 Million ≈ $30.93 Million |
-3.99% |
| 2019-12-31 | RM128.32 Million ≈ $32.22 Million |
-13.04% |
| 2018-12-31 | RM147.57 Million ≈ $37.05 Million |
+23.86% |
| 2017-12-31 | RM119.15 Million ≈ $29.91 Million |
+12.18% |
| 2016-12-31 | RM106.21 Million ≈ $26.67 Million |
-- |
About Sunzen Biotech Bhd
Sunzen Group Berhad, an investment holding company, engages in the biotechnology research and development, manufacturing, and marketing of animal feed supplement products in Malaysia, China, Singapore, and internationally. It operates through Human Health, Medical Devices and Services, and Loan Financing segments. The company provides veterinary, pharmaceutical, chemical products, animal health, … Read more